Topical antimetabolites.
D000963:Antimetabolites / Q000008:administration & dosage* / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D005472:Fluorouracil / Q000008:administration & dosage; D005493:Folic Acid Antagonists / Q000008:administration & dosage; D006801:Humans; D007642:Keratosis / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage; D009182:Mycosis Fungoides / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage; D009824:Ointments; D011033:Podophyllin / Q000008:administration & dosage; D011230:Precancerous Conditions / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D014777:Virus Diseases / Q000188:drug therapy
D000963:Antimetabolites; D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D009588:Nitrogen Mustard Compounds; D009824:Ointments; D011033:Podophyllin; D005472:Fluorouracil; D008727:Methotrexate